GLP-1 Medications and Eating Disorders: Risks and Considerations

Understanding Eating Disorder Classifications

• 💡 Avoidant Restrictive Food Intake Disorder (ARFID) is a restrictive eating disorder where the cause of restriction differs from anorexia, often stemming from sensory issues or fear of eating.
• 🧩 Other Specified Feeding and Eating Disorder (OSFED) is a category for eating disorders that don't meet the full criteria for anorexia, bulimia, binge eating disorder, or ARFID.
• ⚠️ Unspecified Eating Disorder is used when a diagnosis is not yet determined during the initial workup.

Navigating Patient Conversations

• 💬 When discussing sensitive topics like eating disorders, asking for permission to delve deeper into a patient's history is crucial.
• 🤝 Leading with the patient's own language and using openings they provide can facilitate trust and openness.
• 🩺 A comprehensive intake involves exploring diet history, family dynamics around food, potential trauma, and past weight fluctuations.

GLP-1s and Eating Disorder Risks

• ⚠️ GLP-1 receptor agonists may be contraindicated in active restrictive eating disorders due to potential interference with nutritional rehabilitation and the normalization of hunger/fullness cues.
• 📈 In patients with a history of bulimia or binge eating disorder, GLP-1s require careful consideration due to the risk of rebound binging upon discontinuation and potential interference with recovery.
• 🧠 While GLP-1s may quiet "food noise" and reduce urges, their impact on the ability to experience hunger and fullness can hinder long-term recovery.

Clinical Approach and Management

• 🎯 For patients with eating disorders, a multidisciplinary team approach including a therapist, dietitian, and medical monitoring is fundamental.
• 🩺 Key medical monitoring for purging behaviors includes checking for cardiac instability (bradycardia, postural tachycardia) and electrolyte imbalances.
• ⚖️ The term "obesity" is often avoided in eating disorder care due to its stigmatizing nature, with a shift towards weight-inclusive care and focusing on health behaviors rather than weight alone.